Tridentata Posted January 12 Share Posted January 12 The research was done using a couple of antipsychotic drugs, and I don't know whether this would be generalizable to other antidepressants. But for what it's worth: https://www.drugs.com/news/patients-psychiatric-meds-often-gain-weight-scientists-may-now-know-why-116994.html Amitriptyline: prescribed 10 mg/day in mid-August 2022 Began fairly quick taper 18 October 2022 to 3 mg by 9 November (no withdrawal symptoms) Reinstated at 10 mg on 9 November leading to some serious sleep disturbance 10–17 November, tried 8 or 9 mg 18 November, 10 mg 19–22 November, 3.5 mg after advice to drop back to taper level 23 November – 14 Dec., 3 mg 15–22 Dec., 2.7 mg 23 Dec. 2022 to 3/15/2023, ranged from 2.5 mg up to 3 mg w/partial reinstatement after bad crash provoked by CBD/THC gummy, then slowly back down to 2.5 with long hold in March from 15 March 2023, continued slow taper (Brassmonkey slide, 2.5% week + 2 week hold every 4 weeks) to 1.2 mg as of 1/1/24. Increased tapering speed to 20% in 6 weeks, probably bad idea. Other medications: albuterol inhaler as needed, acetaminophen as needed Supplements: daily multivitamin, magnesium glycinate 400 mg/day PRN, probiotics Caffeine: Max 1 cup coffee/day or 2 cups of tea Link to comment Share on other sites More sharing options...
Recommended Posts